Insights

Gathering insights about Instylla…

Similar companies to Instylla

Instylla Tech Stack

Instylla uses 8 technology products and services including WordPress, Open Graph, RSS, and more. Explore Instylla's tech stack below.

WordPress
Content Management System
Open Graph
Content Management System
RSS
Content Management System
Google Workspace
Email
Font Awesome
Font Scripts
Yoast SEO Premium
Search Engines
Nginx
Web Servers
Apache
Web Servers

Media & News

Instylla, Inc. launched FDA 510 clearance of the Tembo Embolic System on Jan 28th '25.
Jan. 28, 2025 - Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo Embolic System.
Jan 29, 2025 | www.dicardiology.com
Instylla, Inc. received financing of $30M in financing round on Aug 15th '23.
Instylla closes USD 30M equity financing.
Aug 16, 2023 | www.explorebit.io
Delos Capital invested into Instylla, Inc. $30M on Aug 18th '23.
Instylla Inc., a medical equipment manufacturing startup based in Bedford, announced earlier this week it closing of a $30 million financing round led by new investor Delos Capital.
Aug 16, 2023 | www.bizjournals.com
Instylla, Inc. hires Henry Chen as Board of Directors.
As part of this round of financing, Henry Chen, Managing Partner, Delos Capital has joined the Instylla Board of Directors.
Aug 14, 2023 | www.prnewswire.com
Instylla, Inc. launched patient in the HALT Study [i] for the treatment of peripheral arterial bleeds on Jan 11th '23.
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the enrollment of the first patient in the HALT Study [i] for the treatment of peripheral arterial bleeds at MemorialCare Long Beach Medical Center.
Jan 12, 2023 | www.oc-breeze.com
Instylla, Inc. launched patient in the HALT Study 1 on Jan 10th '23.
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the enrollment of the first patient in the HALT Study 1 for the treatment of peripheral arterial bleeds.
Jan 10, 2023 | www.prnewswire.com
Instylla, Inc. launched patients in the Embrace Hydrogel Embolic System global randomized clinical trial for the treatment of hypervascular tumors on Mar 30th '21.
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the enrollment of the first patients in the Embrace Hydrogel Embolic System (HES™) global randomized clinical trial for the treatment of hypervascular tumors.
Mar 30, 2021 | www.prnewswire.com

Instylla's Email Address Formats

Instylla uses at least 1 format(s):

Instylla Email Formats	Example	Percentage
FirstL@instylla.com	JohnD@instylla.com	50%
FirstL@instylla.com	JohnD@instylla.com	50%

Frequently Asked Questions

Where is Instylla's headquarters located?

Instylla's main headquarters is located at 201 Burlington Rd Bedford, Massachusetts 01730 US. The company has employees across 2 continents, including North AmericaAsia.

What is Instylla's official website and social media links?

Instylla's official website is instylla.com and has social profiles on LinkedIn.

What is Instylla's NAICS code?

Instylla's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Instylla have currently?

As of December 2024, Instylla has approximately 44 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Of Research & Development And Operations: B. B.Vice President Clinical Affairs: L. M.President: R. L.. Explore Instylla's employee directory with LeadIQ.

What industry does Instylla belong to?

Instylla operates in the Medical Equipment Manufacturing industry.

What technology does Instylla use?

Instylla's tech stack includes WordPressOpen GraphRSSGoogle WorkspaceFont AwesomeYoast SEO PremiumNginxApache.

What is Instylla's email format?

Instylla's email format typically follows the pattern of . Find more Instylla email formats with LeadIQ.

How much funding has Instylla raised to date?

As of December 2024, Instylla has raised $30M in funding. The last funding round occurred on Aug 15, 2023 for $30M.

When was Instylla founded?

Instylla was founded in 2017.

Instylla

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Instylla is focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.

Caution: Investigational Device. Limited by Federal (or US) law to Investigational use only. Not available for sale.